Labcorp 4Q Profit Rises on Diagnostics Growth

Dow Jones

Feb 17

By Nicholas G. Miller

Labcorp posted higher fourth-quarter profit boosted by growth in its diagnostic laboratories business.

The company reported net income of $164.7 million, or $1.98 a share, up from $143.4 million, or $1.70 a share, the year prior.

Adjusted earnings were $4.07 a share. Analysts polled by FactSet expected $3.94 a share.

Revenue rose to $3.52 billion from $3.33 billion. Wall Street expected $3.56 billion.

The company said growth was driven by its diagnostics laboratories segment, which saw revenue rising 5.5% to $2.73 billion.

The company guided for 2026 revenue of $14.61 billion to $14.79 billion and adjusted earnings of $17.55 to $18.25 a share.

Analysts see 2026 revenue of $14.64 billion and adjusted earnings of $17.54 a share.

Write to Nicholas G. Miller at nicholas.miller@wsj.com.

(END) Dow Jones Newswires

February 17, 2026 07:05 ET (12:05 GMT)

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/news/2612143451"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2612143451\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2612143451?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-02-17 20:05","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2612143451","market":"sg","top_or_hot":-1,"title":"Labcorp 4Q Profit Rises on Diagnostics Growth","media":"Dow Jones","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  By Nicholas G. Miller \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  Labcorp posted higher fourth-quarter profit boosted by growth in its diagnostic laboratories business. \n</p>\n<p>\n  The company reported net income of $164.7 million, or $1.98 a share, up from $143.4 million, or $1.70 a share, the year prior. \n</p>\n<p>\n  Adjusted earnings were $4.07 a share. Analysts polled by FactSet expected $3.94 a share. \n</p>\n<p>\n  Revenue rose to $3.52 billion from $3.33 billion. Wall Street expected $3.56 billion. \n</p>\n<p>\n  The company said growth was driven by its diagnostics laboratories segment, which saw revenue rising 5.5% to $2.73 billion. \n</p>\n<p>\n  The company guided for 2026 revenue of $14.61 billion to $14.79 billion and adjusted earnings of $17.55 to $18.25 a share. \n</p>\n<p>\n  Analysts see 2026 revenue of $14.64 billion and adjusted earnings of $17.54 a share. \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  Write to Nicholas G. Miller at nicholas.miller@wsj.com. \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  February 17, 2026 07:05 ET (12:05 GMT)\n</p>\n<p>\n  Copyright (c) 2026 Dow Jones &amp; Company, Inc.\n</p>\n</font>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Labcorp 4Q Profit Rises on Diagnostics Growth</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nLabcorp 4Q Profit Rises on Diagnostics Growth\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2026-02-17 20:05</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<font class=\"NormalMinus1\" face=\"Arial\">\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  By Nicholas G. Miller \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  Labcorp posted higher fourth-quarter profit boosted by growth in its diagnostic laboratories business. \n</p>\n<p>\n  The company reported net income of $164.7 million, or $1.98 a share, up from $143.4 million, or $1.70 a share, the year prior. \n</p>\n<p>\n  Adjusted earnings were $4.07 a share. Analysts polled by FactSet expected $3.94 a share. \n</p>\n<p>\n  Revenue rose to $3.52 billion from $3.33 billion. Wall Street expected $3.56 billion. \n</p>\n<p>\n  The company said growth was driven by its diagnostics laboratories segment, which saw revenue rising 5.5% to $2.73 billion. \n</p>\n<p>\n  The company guided for 2026 revenue of $14.61 billion to $14.79 billion and adjusted earnings of $17.55 to $18.25 a share. \n</p>\n<p>\n  Analysts see 2026 revenue of $14.64 billion and adjusted earnings of $17.54 a share. \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  Write to Nicholas G. Miller at nicholas.miller@wsj.com. \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  February 17, 2026 07:05 ET (12:05 GMT)\n</p>\n<p>\n  Copyright (c) 2026 Dow Jones &amp; Company, Inc.\n</p>\n</font>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LU0742534661.SGD","symbol_name":"Fidelity America A-SGD (hedged)","start_time":0,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2612143451","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2612143451","pubTimestamp":1771329900,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"Labcorp posted higher fourth-quarter profit boosted by growth in its diagnostic laboratories business.The company reported net income of $164.7 million, or $1.98 a share, up from $143.4 million, or $1.70 a share, the year prior.Adjusted earnings were $4.07 a share. Analysts polled by FactSet expected $3.94 a share.Revenue rose to $3.52 billion from $3.33 billion. Wall Street expected $3.56 billion.The company said growth was driven by its diagnostics laboratories segment, which saw revenue rising 5.5% to $2.73 billion.The company guided for 2026 revenue of $14.61 billion to $14.79 billion and adjusted earnings of $17.55 to $18.25 a share.Analysts see 2026 revenue of $14.64 billion and adjusted earnings of $17.54 a share.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"LU0742534661.SGD":"Fidelity America A-SGD (hedged)","LH":"徕博科","LU0006061336.USD":"Blackrock US Small and MidCap Opportunities A2 USD","LU2237438978.USD":"Amundi Funds US Pioneer A2 (C) USD","LU0048573561.USD":"FIDELITY AMERICA \"A\" (USD) INC","BK4585":"ETF&股票定投概念","LU0251142724.SGD":"Fidelity America A-SGD","LU0251131958.USD":"FIDELITY AMERICA \"A\" (USD) ACC","BK4196":"保健护理服务","BK4588":"碎股","LU1059921491.USD":"NORDEA 1 GLOBAL STABLE EQUITY \"HB\" (USDHDG) ACC","BK4550":"红杉资本持仓"},"translate_title":"Labcorp第四季度利润因诊断业务增长而增长","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"LH":0.9},"content_text":"By Nicholas G. Miller \n\n\n \n\n\n  Labcorp posted higher fourth-quarter profit boosted by growth in its diagnostic laboratories business. \n\n\n  The company reported net income of $164.7 million, or $1.98 a share, up from $143.4 million, or $1.70 a share, the year prior. \n\n\n  Adjusted earnings were $4.07 a share. Analysts polled by FactSet expected $3.94 a share. \n\n\n  Revenue rose to $3.52 billion from $3.33 billion. Wall Street expected $3.56 billion. \n\n\n  The company said growth was driven by its diagnostics laboratories segment, which saw revenue rising 5.5% to $2.73 billion. \n\n\n  The company guided for 2026 revenue of $14.61 billion to $14.79 billion and adjusted earnings of $17.55 to $18.25 a share. \n\n\n  Analysts see 2026 revenue of $14.64 billion and adjusted earnings of $17.54 a share. \n\n\n \n\n\n  Write to Nicholas G. Miller at nicholas.miller@wsj.com. \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  February 17, 2026 07:05 ET (12:05 GMT)\n\n\n  Copyright (c) 2026 Dow Jones & Company, Inc.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"dataReport","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":true,"code":"91000000","status":"200"}}}